In This Section
Dr. Bassiri studies the ways in which the immunometabolic features of lymphocytes are altered within solid tumor environments, and how modulating these features may enhance anti-tumor immunity.
Dr. Bassiri has long been interested in the interplay between nonconventional lymphocytes (e.g. natural killer T cells or natural killer cells) and their contribution to anti-tumor immunity.
Recently, he and his lab team have focused their studies on elucidating the immunometabolic features of invariant natural killer T cells that may allow them to be used as a platform for cellular immunotherapy of high-risk pediatric solid tumors such as neuroblastoma.
Dr. Bassiri's current projects include directing natural killer T and natural killer cell anti-tumor responses, natural killer T cell immunometabolism and function, and altering the neuroblastoma immune environment to control tumor growth.
Education and Training
BA, University of Pennsylvania (Biology), 1991
PhD, University of Pennsylvania School of Medicine (Immunology), 2002
MD, University of Pennsylvania School of Medicine, 2004
Fellowship, Children's Hospital of Philadelphia (Pediatric Infectious Diseases), 2010
Titles and Academic Titles
Assistant Professor of Pediatrics
Infectious Diseases Society of America, 2007-
Pediatric Infectious Diseases Society, 2007-
Clinical Immunology Society, 2008-
American Association of Pediatrics, 2011-
Eastern Society for Pediatric Research, 2014-
Pediatric Academic Societies, 2015-
Society for Pediatric Research, 2015-
American Association for Cancer Research, 2016-
American Association of Immunologists, 2016-
American Society of Hematology, 2016-
Teddy Bedrosian Compassionate Care Award, Children's Hospital of Philadelphia, 2006
Clinical Immunology Society/Talecris Biotherapeutics
Fellowship Award, 2009
Clinical Immunology Society/Talecris Biotherapeutics Senior Fellow Award, 2010
Young Faculty Investigator finalist, Eastern Society for
Pediatric Research, 2014